
Medreich Limited
Bengaluru, India medreich.com From their website, Nov 2026
Work here? Claim this listing
About
Medreich Limited is a pharmaceutical CMO and CDMO that develops, manufactures, and packages dosage forms for regulated and emerging markets. It serves customers in India, the UK, Australia, New Zealand, Europe, Canada, Far East Asia, GCC, Africa, LATAM, and CIS from sites in Bengaluru, Australia, and the United Kingdom.
Services
Proof of Concept
Develops novel drug delivery dosage forms using broad technology platforms and smaller-scale R&D batches to assess API, salt, and polymorphic form feasibility.
Formulation Development
Develops oral solid dosage forms including modified, controlled, and FDC immediate-release formulations, as well as liquids, suspensions, emulsions, semisolids, and creams.
Analytical Services
Provides analytical method development, validation, technology transfer, API characterization, impurity profiling, solubility and dissolution studies, polymorphic studies, stability studies, and microbiological testing.
Clinical Manufacturing
Provides cGMP manufacturing for bio batch products including tablets and capsules, and supports bioavailability and bioequivalence study design, execution, analysis, and dossier compilation.
Commercial Manufacturing
Manufactures tablets, capsules, dry powders for suspensions, and dry powder for injections in six manufacturing facilities under GMP and quality management systems.
Packaging Design & Development
Designs primary and secondary packaging, artwork, labeling, containerization, and anti-counterfeit features for multiple dosage forms and pack configurations.
Regulatory
Supports regulatory filings in CTD format, market authorization applications, CMC documentation, product information, labeling, post-approval maintenance, variations, and renewals.
Pharmacovigilance
Processes adverse event cases, including triage, case entry, follow-up, narrative writing, quality review, medical review, PSUR compilation, signal detection, and risk-benefit analysis.
- What to send
- API / salt / polymorphic form for proof of concept studies
Capabilities
- Assays and studies
- Analytical development
- Stability studies
- Analytical method development
- Method validation
- Technology transfer
- API characterization
10 more
- Impurity profiling
- Solubility studies
- Dissolution studies
- Multi-media dissolution
- Diffusion studies
- Polymorphic studies
- Photo stability studies
- Microbiological testing
- Bioavailability studies
- Analytical method validation
- Scale and capacity
- Smaller scale R&D batches
- Batch sizes ranging from a few thousand units to over a million units per batch
- Six state of the art manufacturing facilities
- Two stability centers equipped with walk-in chambers
- A team of 45+ regulatory experts
- Close to 4000 employees worldwide
- Six manufacturing facilities
- Therapeutic areas
- Diverse therapeutic categories
Modalities and species
- Modalities
- Small molecule
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: Clinical manufacturing and commercial manufacturing
Industries served
- Pharmaceuticals
Company
- Type
- CDMO
- Founded
- 2015
- Size
- 1001-5000 employees
- Quality
- cGMP (Bio Batch products) · GMP (manufacturing facilities) · ICH (stability studies and bioequivalence studies) · QMS (all units) · eQMS (quality management system) · QLMS (quality control laboratory management) · USFDA (bioequivalence study site inspection context) · UK MHRA (manufacturing facility approval context) · TGA Australia (manufacturing facility approval context) · Health Canada (manufacturing facility approval context) · PMDA Japan (manufacturing facility approval context) · MFDS South Korea (manufacturing facility approval context) · MCC South Africa (manufacturing facility approval context) · PICS (manufacturing facility compliance context) · ICH guidelines (Stability studies and bioequivalence studies) · Current Good Clinical Practices (Bioequivalence studies) · Good Laboratory practices (Bioequivalence studies)
Locations
- Office
- 21 Underwood Road, Homebush Business Village Homebush New South Wales 2140 Australia
- Sites
- Homebush, Australia
- Feltham London, United Kingdom
- Feltham, United Kingdom
- Serves
- India, Japan, Australia & New Zealand, United Kingdom, Rest of Europe, Canada, Far East Asia, GCC, Africa, LATAM, CIS
Contacts
- Phone
- ++91 80 40487100